BD Biosciences solutions for HIV provides absolute and percentage results of CD4 T lymphocytes to stage progression of HIV/AIDS, to guide treatment decisions for HIV-infected persons, and to evaluate the effectiveness of therapy.

Our commitment to help prevent, diagnose, and treat HIV/AIDS goes beyond the application of technology. We actively collaborate across public and private sectors to create effective and sustainable programs to build healthcare capacity.

BD collaborates across the private and public sectors to create effective and sustainable programs that help build healthcare capacity.

Of the more than 35.3 million people worldwide infected with HIV, only about 11.7 million have access to treatment (2013)*. The WHO goal is to increase that number to 15 million by 2015. According to the WHO 2013 guidelines, close to 26 million people are eligible for antiretroviral therapy (ART). As diagnostics, therapies, and healthcare infrastructure become more accessible, estimating CD4 lymphocyte counts guides initiation of ART and becomes a critical link in monitoring HIV infection and disease progression.

BD Biosciences instruments and reagents are used in CD4 testing. The BD FACSCount™ system is used in developing areas of the world where easy-to-use systems are needed. The BD FACSCalibur™ system is used in high-volume labs in resource-limited settings, and the BD FACSCanto™ II system is used for HIV monitoring and other applications when more sophisticated technologies are required.

* Does not constitute medical or legal advice, including with respect to regulatory practices or industry standards, specifically 21 CFR Part 58 Good Laboratory Practice for Nonclinical Laboratory Studies.

* Fact sheet: World Health Organization – HIV/AIDS fact sheet (2013); UNAIDS Treatment 2015; Global Update on the health sector response to HIV, WHO Executive Summary - July 2014

This site uses cookies. If you click accept cookies then all cookies will be written. Please review our cookies policy and configure your cookies for your experience. 

希腊传说注册 甘肃十一选五今天预测 青海十一选五开 吉林时时走势图开奖 一部手机也能赚钱吗 黑龙江快乐十分走势图开奖结果查询 七乐彩号码 提炼技巧 上海快3一定牛走势图 快乐10分胆拖玩法 新疆时时彩组三技巧 p3组选237后 做国际劳务输出赚钱吗 现在注册滴滴还能赚钱 cf小丑模式贴吧 舟山飞鱼基本走势图 浙江十一选五开奖结 天津快乐十分前三组最多遗漏多少期